ETFIQ
RankingsCompareHoldingsResearch
My portfolioWeekly note

TMED · T. Rowe Price Health Care ETF

Equity fundActively managed0.44% fee$23mSince Jun 12, 2025SEC filings ↗
Share on XDownload as PDFCompareAdd to portfolioAlerts

TMED is actively managed and returned +21.4% over the past year.

+21.4%
Total return, 1 year
0.44%
Expense ratio
96
Holdings
−9.4%
Below its high
WindowTotal returnS&P 500Gap to S&P 500Gap to Nasdaq-100
3M Jul 2 – Oct 2, 2026−5.1%+3.6%−8.7 pts−10.4 pts
6M Apr 2 – Oct 2, 2026+13.2%+17.9%−4.8 pts−15.2 pts
1Y Oct 2, 2025 – Oct 2, 2026+21.4%+16.2%+5.2 pts−2.9 pts
Since listing Jun 12, 2025 – Oct 2, 2026+32.9%+29.6%+3.3 pts−8.5 pts

TMED over each window to Oct 2, 2026. Every figure is an ETFIQ calculation. Source: ETFIQ.

TMED top ten by weight, 47.9% of its 96 equity positions, from the holdings filed for Jun 30, 2026. An index fund holds what the index holds, so this is the index. Source: the fund’s SEC filing.

ELI LILLY & CO 16.84%
UNITEDHEALTH GROUP INC 6.57%
GILEAD SCIENCES INC 4.47%
THERMO FISHER SCIENTIFIC INC 4.14%
DANAHER CORP 2.98%
CENCORA INC 2.77%
AGILENT TECHNOLOGIES INC 2.63%
ALNYLAM PHARMACEUTICALS INC 2.62%
INTUITIVE SURGICAL INC 2.45%
INSULET CORP 2.40%
Fund filings on SEC EDGAR ↗
Head to head
Funds near this one
ACWIACWXAIRRAORAVDVAVEM

In plain words

TMED is actively managed and tracks no index. Over the year to Oct 2, 2026 it returned +21.4% with distributions reinvested, against +16.2% for the S&P 500 and +24.3% for the Nasdaq-100. The prospectus expense ratio is 0.44% a year. By its holdings filed for Jun 30, 2026, 66% of the fund by weight is stocks the S&P 500 also holds, across 96 positions, with the top ten at 47.9%. It sat 9.4% below its high of Aug 19, 2026 on Oct 2, 2026.
What it tracksNo index, actively managed
Fund typeEquity fund
Category (ETFIQ)Stocks · Health care
Expense ratio (485BPOS XBRL, Feb 25, 2026)0.44%
Price$33.22
Listed sinceJun 12, 2025
Net assets (SEC filing, whole fund, as filed for Jun 30, 2026)$23m
Below its high (ETFIQ)−9.4%
Holdings96
Top ten weight47.9%
Holdings as of (SEC N-PORT)Jun 30, 2026
Already in the S&P 500, by weight (ETFIQ)65.8%
Active share vs the S&P 500 (ETFIQ)95.4%
Already in the Nasdaq-100, by weight (ETFIQ)12.2%
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

Questions people ask about TMED

How has TMED performed?
Over the year to Oct 2, 2026, TMED returned +21.4% with distributions reinvested, against +16.2% for the S&P 500. Over three years the figure is not published.
What does TMED cost?
The prospectus expense ratio is 0.44% a year.
What does TMED hold?
96 positions as filed for Jun 30, 2026, with the top ten at 47.9% of the fund. 66% of its weight is in stocks the S&P 500 also holds.
How far is TMED below its high?
9.4% below its high of Aug 19, 2026, measured on the reinvested series to Oct 2, 2026.
Sources and dates
Prices, TMED and S&P 500Tiingo end-of-day · Oct 2, 2026
Fee, 0.44%Prospectus filing with the expense ratio (SEC) ↗
Net assets, $23mSEC filing, whole fund · Jun 30, 2026
HoldingsHoldings filing (SEC Form N-PORT) · Jun 30, 2026 ↗
IssuerT. Rowe Price website ↗
All fund filingsFund filings on SEC EDGAR ↗
SourceT. Rowe Price’s own site ↗

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

ETFIQ covers core, leveraged and inverse, buffer, thematic, option-income, alternatives and spot crypto ETFs. This fund is here because the other funds here are measured against it and portfolios hold it. ETFIQ is an independent publisher and makes no recommendations. Standards and sources

How these figures are computed →Standards and sources →Open data →
Cite this page

ETFIQ, TMED, core fund, data as of Oct 2, 2026. https://etfiq.com/funds/tmed

Free to use with attribution; the underlying files are at Open data.

T. Rowe Price: every fund ETFIQ covers→